Skip to main content

Table 1 Demographic and baseline clinical data

From: A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease

 

Total n = 18

Interventionn = 11

Waitlist n = 7

p-value*

Gender, n (%)

    

  Male

12 (67%)

9 (82%)

3 (43%)

 

  Female

6 (33%)

2 (18%)

4 (57%)

 

Age, M (SD)

66 (8.26)

68 (7.72)

62 (8.34)

.17

PD duration (M years, SD)

5.12 (4.61)

5.70 (5.50)

4.29 (3.15)

.55

Age of PD onset, M (SD)

61.82 (7.47)

64.10 (7.82)

58.57 (6.00)

.13

Mean H&Y stage

II

II

II

 

Taking antidepressants, n (%)

11 (61%)

6 (55%)

5 (74%)

 

DSM-IV-TR diagnosis, n (%)

    

  Generalised anxiety

12 (66%)

8 (73%)

4 (57%)

 

  Panic attacks and/or disorder

7 (39%)

4 (35%)

3 (43%)

 

  Major depressive disorder

6 (33%)

2 (18%)

4 (57%)

 

  Dysthymia

6 (33%)

3 (27%)

3 (43%)

 

  Social anxiety

4 (22%)

1 (9%)

3 (43%)

 

  Posttraumatic stress disorder

1 (5%)

0

1 (14%)

 

Primary outcomes, M (SD)

    

  DASS-D

10.44 (4.23)

10.09 (3.73)

10.71 (5.41)

.99

  DASS-A

9.06 (3.35)

9.64 (2.01)

8.57 (4.61)

.72

  DASS-S

9.78 (3.83)

10.64 (3.26)

10.00 (4.28)

.56

Secondary outcomes, M (SD)

    

  PDQ-39

34.97 (13.07)

36.03 (12.62)

28.48 (16.15)

.27

  CCL-D

30.29 (13.30)

31.22 (15.50)

24.49 (14.12)

.32

  CCL-A

32.41 (12.19)

32.01 (10.51)

29.46 (14.00)

.62

  1. DASS-D = DASS-Depression, DASS-A = DASS-Anxiety, DASS-S = DASS-Stress, PDQ-39 = Parkinson’s Disease Questionnaire-39, CCL-D = Cognitions Checklist-Depressive Cognitions, CCL-A = Cognitions Checklist-Anxious Cognitions.
  2. *p-value for Independent t-test on baseline differences between Intervention and Waitlist groups.